alexa Recurrent Glioblastoma Innovations Open Access |OMICS International| Chemotherapy: Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recurrent Glioblastoma Innovations

Malignant gliomas remain refractory to the standard therapy of surgical debulking followed by radiation. They are also universally fatal with a median survival still under 12 months and death usually occurring 40 to 50 weeks from initial diagnosis. Both single and combination chemotherapeutic treatments have been attempted. Although some combination treatments appear to show promise as effective strategies, clinical trials confirming their safety and efficacy remain to be performed.Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top